3,3′-Diindolylmethane Dose-Dependently Prevents Advanced Prostate Cancer
Y. Li, N. W. Mahloch, N. J. E. Starkey, M. Pena-Luna, G. E. Rottinghaus, K. L. Fritsche, C. Besch-Williford, D. B. Lubahn
Abstract
3,3'-Diindolylmethane (DIM) is an acid-derived dimer of indole-3-carbinol, found in many cruciferous vegetables, such as broccoli, and has been shown to inhibit prostate cancer (PCa) in several in vitro and in vivo models. We demonstrated that DIM stimulated both estrogen receptor alpha (ER) and estrogen receptor beta (ER{beta}) transcriptional activities and propose that ER{beta} plays a role in mediating DIMs inhibition on cancer cell growth. To further study the effects of DIM on inhibiting advanced PCa development, we tested DIM in TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. The control group of mice were fed a high fat diet. Three additional groups of mice were fed the same high fat diet supplemented with 0.04%, 0.2% and 1% DIM. Incidence of advanced PCa, poorly differentiated carcinoma (PDC), in the control group was 60%. 1% DIM dramatically reduced PDC incidence to 24% (p=0.0012), while 0.2% and 0.04% DIM reduced PDC incidence to 38% (p=0.047) and 45% (p=0.14) respectively. Though DIM did affect mice weights, statistical analysis showed a clear negative association between DIM concentration and PDC incidence with p=0.004, while the association between body weight and PDC incidence was not significant (p=0.953). In conclusion, our results show that dietary DIM can inhibit the most aggressive stage of prostate cancer at concentration lower than previously demonstrated, possibly working through an estrogen receptor mediated mechanism.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveal the potential role of ketogenesis to slow tumor growth: A secondary analysis of the CAPS2 diet trial
J.-T. A. Chi, P.-H. Lin, … S. Freedland·bioRxiv·Dec 29, 2021
- Protein kinase D promotes prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner
- Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer
- Effects of Polyunsaturated Fatty Acids and Selenoneine on Growth and Lipidomic Profiles in Patient-Derived Prostate Cancer Organoids
Mame Sokhna Sylla, Cynthia Jobin, … Étienne Audet‐Walsh·bioRxiv·Sep 7, 2026
- Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma
C. S. Koivisto, M. Parrish, … G. Leone·bioRxiv·Dec 6, 2019
- IR-B deficiency and fatty acid dysregulation accelerate prostate cancer progression via PI3K/AKT signaling
Gena Huang, Athba Alqahtani, … Yingjie Wu·bioRxiv·Feb 2, 2026